CEL-SCI CORPORATION Stock Issued During Period, Shares, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CEL-SCI CORPORATION stock issued during period, shares, issued for services for the quarter ending 2023-03-31 was 38.56K shares, a 51.37% increase year-over-year.
- CEL-SCI CORPORATION stock issued during period, shares, issued for services for the quarter ending 2022-03-31 was 25.48K shares.
- CEL-SCI CORPORATION stock issued during period, shares, issued for services for the quarter ending 2018-12-31 was 62.78K shares, a 358.11% increase year-over-year.
- CEL-SCI CORPORATION stock issued during period, shares, issued for services for the quarter ending 2018-06-30 was 81.60K shares, a 3.82% increase year-over-year.
- CEL-SCI CORPORATION stock issued during period, shares, issued for services for fiscal 2020 was 79.95K shares, a 60.02% decline from fiscal 2019.
- CEL-SCI CORPORATION stock issued during period, shares, issued for services for fiscal 2019 was 199.98K shares.
- CEL-SCI CORPORATION stock issued during period, shares, issued for services for fiscal 2014 was 3.12M shares.
| Period end | Stock Issued During Period, Shares, Issued for Services 3 month | Stock Issued During Period, Shares, Issued for Services 12 month |
|---|---|---|
| 2023-03-31 | 38.56K shares 10-Q · filed 2023-05-12 | |
| 2022-03-31 | 25.48K shares 10-Q · filed 2023-05-12 | |
| 2020-09-30 | 79.95K shares 10-K · filed 2020-12-29 | |
| 2019-09-30 | 199.98K shares 10-K · filed 2020-12-29 | |
| 2018-12-31 | 62.78K shares 10-Q · filed 2019-02-14 | |
| 2018-06-30 | 81.60K shares 10-Q · filed 2018-08-14 | |
| 2018-03-31 | 19.00K shares 10-Q · filed 2018-05-15 | |
| 2017-12-31 | 13.71K shares 10-Q · filed 2019-02-14 | |
| 2017-06-30 | 78.60K shares 10-Q · filed 2018-08-14 | |
| 2017-03-31 | 4.10K shares 10-Q · filed 2018-05-15 | |
| 2016-12-31 | 14.90K shares 10-Q · filed 2018-02-12 | |
| 2014-09-30 | 3.12M shares 10-K · filed 2014-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |